The underrepresentation of older adults in clinical trials of Janus kinase inhibitors in the treatment of atopic dermatitis

被引:7
作者
Sreekantaswamy, Shreya A. [1 ]
Tully, Janell [2 ,3 ]
Edelman, Linda S. [4 ]
Supiano, Mark A. [5 ]
Butler, Daniel
机构
[1] Univ Utah, Sch Med, Salt Lake City, UT USA
[2] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA
[3] Univ Arizona, Coll Med, Phoenix, AZ USA
[4] Univ Utah, Coll Nursing, Salt Lake City, UT USA
[5] Univ Utah, Div Geriatr, Salt Lake City, UT USA
关键词
atopic dermatitis; clinical trials; eczema; geriatric; JAK inhibitors; older adults;
D O I
10.1016/j.jaad.2022.02.051
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1174 / 1176
页数:3
相关论文
共 5 条
[1]   Never too old?: Age should not be a barrier to enrollment in cancer clinical trials [J].
Aapro, MS ;
Köhne, CH ;
Cohen, HJ ;
Extermann, M .
ONCOLOGIST, 2005, 10 (03) :198-204
[2]   The epidemiology of atopic dermatitis in older adults: A population-based study in the United Kingdom [J].
Chan, Leslie N. ;
Magyari, Alexa ;
Ye, Morgan ;
Al-Alusi, Noor A. ;
Langan, Sinead M. ;
Margolis, David ;
McCulloch, Charles E. ;
Abuabara, Katrina .
PLOS ONE, 2021, 16 (10)
[3]   Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review [J].
Lam, Megan ;
Zhu, Jie Wei ;
Maqbool, Talha ;
Adam, Gaelen ;
Tadrous, Mina ;
Rochon, Paula ;
Drucker, Aaron M. .
JAMA DERMATOLOGY, 2020, 156 (11) :1240-1245
[4]  
Pfizer, PFIZ SHAR COPR ENDP
[5]   Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database [J].
Ruiter, Rikje ;
Burggraaf, Jacobus ;
Rissmann, Robert .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (04) :838-844